Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Marier

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Journal of Oral Surgery (American Dental Association : 1965)|December 1, 1979
Microbiologic and antibiotic aspects of infections in the oral and maxillofacial regionR N Greenberg, R B James, R L Marier, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1983
Comparative clinical trial of imipenem-cilastatin (N-formimidoyl-thienamycin-dehydropeptidase inhibitor) and cefazolinR L Marier, R V McCloskey, G Dickenson, et al.
Annals of Internal Medicine|January 1, 1983
Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in 52 patients. National Institute of Allergy and Infectious Diseases collaborative antifungal studyW E Dismukes, A M Stamm, J R Graybill, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Journal of Oral Surgery (American Dental Association : 1965)|December 1, 1979
Microbiologic and antibiotic aspects of infections in the oral and maxillofacial regionR N Greenberg, R B James, R L Marier, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1983
Comparative clinical trial of imipenem-cilastatin (N-formimidoyl-thienamycin-dehydropeptidase inhibitor) and cefazolinR L Marier, R V McCloskey, G Dickenson, et al.
Annals of Internal Medicine|January 1, 1983
Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in 52 patients. National Institute of Allergy and Infectious Diseases collaborative antifungal studyW E Dismukes, A M Stamm, J R Graybill, et al.
Pageof 4